MMTC planning to export engineering goods, pharma products

As part of its business diversification strategy, MMTC Ltd., the state-owned trading entity, aims to commence exports of engineering goods and pharmaceutical products from Q1 of next fiscal.
The company is looking at transactions in new commodities and go beyond its forte in trade of bullion and major bulk minerals like iron ore and chromite.
“We have already empanelled suppliers for engineering goods exports. They are expected to take off from Q1 of next fiscal. Engineering goods will be primarily exported to African markets. We have also identified some Asian markets like Sri Lanka and Bangladesh,” said a senior MMTC executive.
MMTC is awaiting award of drug license to start exports of pharmaceutical products. Amongst the new pro-ducts identified for trade, minor minerals are targeted for exports alone and will be canalised through MMTC. The other identified commodities are meant for two-way trade. The company has initiated action on exports of minor mine-rals like feldspar and bentonite.
Historically known for its strengths in trade of bulk minerals like iron ore and chrome ore, MMTC is witnessing a downtrend in exports of these minerals in value and volume terms. In FY18, low grade chrome ore and chrome concentrates exports plunged 58% as a steep export tax of 30% weighed on exports. Total volumes exported in last fiscal were only 95,000-tonnes, down from 225,000-tonnes shipped in FY17.
MMTC is one of the premier bullion traders in the country with the precious metals division contributing significantly to its turnover.
The company has delineated a roadmap to double its top-line in the next five years. The surge in turnover is expected to be fuelled by MMTC’s diversification into new business areas.
Looking for chemical products? Let suppliers reach out to you!
2026-06-26
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Pharma Quality Excellence Awards 2026 - Celebration and Conclusion
-
Pharma Quality Reimagined: Highlights from the 6th Annual Pharma GMP & Quality Management 2026
-
From Feedmill to Food System: VIV Europe 2026 Addresses the Industry's Most Critical Challenges
-
Beyond Compliance: Building Quality Maturity
-
Is the class solidified? From Biotech to Pharma
-
The IPO of the Largest Domestic Metronidazole API Manufacturer has Passed the Meeting
-
Progesterone Market Potential is Huge
-
PharmaReg AfriSummit
-
2022 PHARMA X FOOD X FINE CHEMICAL RAW MATERIALS MATCH MEETING Successfully Held!
-
KOREA PHARM & BIO 2021
Recommend Reading
-
West Asia Tensions Squeeze Pharma Raw Materials
-
J&J to Spin Off Orthopedics Business, Raises 2025 Forecast
-
Bayer’s Ambitious Gene & Cell Therapy Pipeline Eyes Parkinson’s, Oncology, Rare Diseases
-
Novo Nordisk Faces a Compliance Test
-
Aspen Secures Approval to Market Lilly’s Mounjaro for Weight Loss in South Africa
-
April DMF Market Prices Show an Initial Rise Followed by a Decline
-
Supply-side disruptions persist, lithium carbonate prices continue to rise
-
This week, the Chinese propylene oxide market shows a significant downward trend
-
This Round Sees the First Retail Price Drop for Refined Oil Products This Year
-
Positive Factors Support Rising Coking Coal Prices